Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ)
CNY 5.53
(-0.36%)
CNY 5.53
(-0.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 848.81 Million CNY | 53.7% |
| 2022 | 552.25 Million CNY | 8.59% |
| 2021 | 508.58 Million CNY | 21.16% |
| 2020 | 419.75 Million CNY | 30.16% |
| 2019 | 322.48 Million CNY | -28.0% |
| 2018 | 447.86 Million CNY | 85.24% |
| 2017 | 241.78 Million CNY | 111.58% |
| 2016 | 114.27 Million CNY | 55.48% |
| 2015 | 73.49 Million CNY | -61.32% |
| 2014 | 190.01 Million CNY | 13.0% |
| 2013 | 168.15 Million CNY | 4.3% |
| 2012 | 161.22 Million CNY | 97.51% |
| 2011 | 81.63 Million CNY | -16.38% |
| 2010 | 97.62 Million CNY | -8.42% |
| 2009 | 106.6 Million CNY | 4.26% |
| 2008 | 102.24 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 887.89 Million CNY | 3.46% |
| 2024 Q1 | 858.17 Million CNY | 1.1% |
| 2023 FY | 848.81 Million CNY | 53.7% |
| 2023 Q4 | 848.81 Million CNY | 1.2% |
| 2023 Q1 | 455.05 Million CNY | -17.6% |
| 2023 Q3 | 838.74 Million CNY | 80.01% |
| 2023 Q2 | 465.95 Million CNY | 2.4% |
| 2022 FY | 552.25 Million CNY | 8.59% |
| 2022 Q4 | 552.25 Million CNY | 13.54% |
| 2022 Q3 | 486.4 Million CNY | -7.59% |
| 2022 Q2 | 526.34 Million CNY | -3.41% |
| 2022 Q1 | 544.89 Million CNY | 7.14% |
| 2021 FY | 508.58 Million CNY | 21.16% |
| 2021 Q1 | 422.5 Million CNY | 0.66% |
| 2021 Q4 | 508.58 Million CNY | 136.14% |
| 2021 Q2 | 298.53 Million CNY | -29.34% |
| 2021 Q3 | 215.37 Million CNY | -27.86% |
| 2020 FY | 419.75 Million CNY | 30.16% |
| 2020 Q1 | 343.93 Million CNY | 6.65% |
| 2020 Q2 | 363.89 Million CNY | 5.8% |
| 2020 Q3 | 411.11 Million CNY | 12.98% |
| 2020 Q4 | 419.75 Million CNY | 2.1% |
| 2019 FY | 322.48 Million CNY | -28.0% |
| 2019 Q4 | 322.48 Million CNY | 20.55% |
| 2019 Q1 | 413.03 Million CNY | -7.78% |
| 2019 Q3 | 267.5 Million CNY | -15.44% |
| 2019 Q2 | 316.35 Million CNY | -23.41% |
| 2018 Q4 | 447.86 Million CNY | 15.32% |
| 2018 Q2 | 341.54 Million CNY | 19.23% |
| 2018 Q1 | 286.44 Million CNY | 18.47% |
| 2018 FY | 447.86 Million CNY | 85.24% |
| 2018 Q3 | 388.35 Million CNY | 13.71% |
| 2017 Q1 | 102.88 Million CNY | -9.96% |
| 2017 FY | 241.78 Million CNY | 111.58% |
| 2017 Q4 | 241.78 Million CNY | 54.97% |
| 2017 Q3 | 156.01 Million CNY | -1.98% |
| 2017 Q2 | 159.16 Million CNY | 54.7% |
| 2016 FY | 114.27 Million CNY | 55.48% |
| 2016 Q1 | 59.75 Million CNY | -18.7% |
| 2016 Q2 | 62.65 Million CNY | 4.87% |
| 2016 Q3 | 59.64 Million CNY | -4.81% |
| 2016 Q4 | 114.27 Million CNY | 91.58% |
| 2015 Q1 | 196.13 Million CNY | 3.22% |
| 2015 Q2 | 185.9 Million CNY | -5.22% |
| 2015 Q3 | 191.31 Million CNY | 2.91% |
| 2015 Q4 | 73.49 Million CNY | -61.58% |
| 2015 FY | 73.49 Million CNY | -61.32% |
| 2014 Q3 | 188.8 Million CNY | -1.13% |
| 2014 Q4 | 190.01 Million CNY | 0.64% |
| 2014 Q1 | 170.46 Million CNY | 1.37% |
| 2014 Q2 | 190.96 Million CNY | 12.03% |
| 2014 FY | 190.01 Million CNY | 13.0% |
| 2013 Q1 | 154.66 Million CNY | -4.07% |
| 2013 FY | 168.15 Million CNY | 4.3% |
| 2013 Q4 | 168.15 Million CNY | 5.27% |
| 2013 Q3 | 159.73 Million CNY | -4.32% |
| 2013 Q2 | 166.95 Million CNY | 7.95% |
| 2012 Q1 | 76.5 Million CNY | -6.29% |
| 2012 Q2 | 77.93 Million CNY | 1.87% |
| 2012 Q3 | 153.49 Million CNY | 96.95% |
| 2012 Q4 | 161.22 Million CNY | 5.04% |
| 2012 FY | 161.22 Million CNY | 97.51% |
| 2011 FY | 81.63 Million CNY | -16.38% |
| 2011 Q1 | 102.69 Million CNY | 5.19% |
| 2011 Q2 | 110.39 Million CNY | 7.5% |
| 2011 Q3 | 86.51 Million CNY | -21.63% |
| 2011 Q4 | 81.63 Million CNY | -5.64% |
| 2010 FY | 97.62 Million CNY | -8.42% |
| 2010 Q4 | 97.62 Million CNY | 0.0% |
| 2009 FY | 106.6 Million CNY | 4.26% |
| 2008 FY | 102.24 Million CNY | 0.0% |